A unique effort to discover new treatments for cancer, the Experimental Therapeutic Unit-IFOM leverages the strong biology and clinical relevance of the whole Campus IFOM and IEO’s research in cancer with industry-competitive drug discovery experience.
This drug discovery unit includes about 30 scientists (lead by Dr Mario Varasi):
The Experimental Therapeutics Unit-IFOM benefits from the TTFactor Advisory Board encompassing international scientific and business experience and it is working in close contact with the biologists at the IFOM-IEO Campus to select promising targets and help them in identifying small molecules to be developed up to an IND with the support of industrial partnerships.
A biology inspired-chemistry driven effort to identify small molecules for innovative therapy against cancer
Dr Carlo Ciani (Chairman of TTF) presents the TT program (in italian)
Interview with Daniela Bellomo (Managing Director of TTF)
Via Adamello, 16 20139 MilanoT: +39 02 94375140 F +39 02 94375991e-mail:
TTFactor S.r.l.Sede legale: Via Ripamonti 435 MilanoSede Operativa Via Adamello 16 MilanoP.IVA/C.F. 07063660968